HAWK

Verizon continues progress on Maui network restoration

Retrieved on: 
Tuesday, August 15, 2023
Civic, American Red Cross, Communication, COLT, RSS, Lahaina Civic Center, VZ, HAWK, Wildfire, Emergency, NYSE, Golf course, Cell, Makawao, Hawaii, Government, Food, Cable television, Road, Communications satellite, Satellite navigation device, Mobile phone, Upcountry, Verizon Communications

HONOLULU, Aug. 14, 2023 (GLOBE NEWSWIRE) -- With its ongoing response to the wildfires, Verizon is focused on reconnecting Maui residents by restoring wireless service and providing communications support to shelters and first responders.

Key Points: 
  • This is not limited to but includes the following locations: Kula, Pukalani, Makawao, and along the North Shore of Maui.
  • 8/10/23 - Verizon restored limited service to a portion of West Maui from Maalaea and the Maui Chin to the South through Lahaina Civic Center to the North.
  • While Verizon works to fully restore the network, there may be inconsistent and partial restoration of network coverage.
  • Headquartered in New York City and with a presence around the world, Verizon generated revenues of $136.8 billion in 2022.

This hurricane season, Verizon readies the fleet

Retrieved on: 
Wednesday, May 24, 2023
CRAN, BAT, COLT, Big Mac, Emergency, WOLF, Atmosphere, Tether, SPOT, HAWK, Wireless router, THOR, MEC, Cyclone, STUD, ENB, Wi-Fi, GOAT, Repeated sequence (DNA), WECC, Military personnel, MEOW, Risk, CROW, Emergency operations center, MCT, Cell, Hurricane season, Lifting, Radio, Mobile asset management, Verizon Communications, Weather, SOW, NOW, Lightweight, SNOW, PIG, LTE, Video, Electric battery, Communications satellite, Satellite navigation device, Mobile telephony, Mobile phone, Intermodal freight transport, Heavy equipment, Trailer

One hundred percent of Verizon macro cell sites which provide large area coverage have backup battery power and 79% have backup generators.

Key Points: 
  • One hundred percent of Verizon macro cell sites which provide large area coverage have backup battery power and 79% have backup generators.
  • In case emergency network recovery becomes necessary after a hurricane makes landfall, Verizon is prepared to respond quickly.
  • Additionally, Verizon boasts an industry-leading 200 satellite-based portable network assets.
  • Verizon Frontline Crisis Response Team members set up portable cell sites, WiFi hotspots, free charging stations and other Verizon Frontline devices and solutions that help enable mission-critical communication and/or boost network performance.

EQS-News: Mynaric optimizes management structure: Mustafa Veziroglu will become sole CEO with Bulent Altan set to join Supervisory Board

Retrieved on: 
Thursday, May 11, 2023
CONDOR, HAWK, Policy, Supervisory board, Lead, FRA, MK2, Supervision, SpaceX, Growth, Management, Mynaric

MUNICH, May 11, 2023 – Mynaric (NASDAQ: MYNA) (FRA: M0YN), a leading provider of industrialized, cost-effective, and scalable laser communications products, today announced that the management and supervisory board jointly decided on a plan to further optimize the leadership structure of Mynaric.

Key Points: 
  • MUNICH, May 11, 2023 – Mynaric (NASDAQ: MYNA) (FRA: M0YN), a leading provider of industrialized, cost-effective, and scalable laser communications products, today announced that the management and supervisory board jointly decided on a plan to further optimize the leadership structure of Mynaric.
  • Mustafa Veziroglu joined Mynaric’s management board in August 2022 and most recently served as Co-CEO of the company leading all operational product-related activities overseeing the entire product lifecycle from development through delivery.
  • His role as CEO will be to strengthen Mynaric’s focus on 2023 execution targets particularly with respect to production and positioning the company for long-term growth.
  • His role as part of the Supervisory Board will be to represent the company externally and to carry Mynaric’s vision of ubiquitous optical communications across the space industry.

EQS-News: Mynaric Announces Preliminary Unaudited Full-Year 2022 Results

Retrieved on: 
Friday, April 28, 2023
Communication, CONDOR, Q&A, HAWK, Central European Summer Time, Northrop, Grumman, FRA, Government, Interest, DARPA, EUR, CFO, Webcast, Security (finance), Management, Mynaric

MUNICH, April 27, 2023 – Mynaric (NASDAQ: MYNA) (FRA: M0YN), a leading provider of industrialized, cost-effective and scalable laser communications products, today announces preliminary unaudited results for the fiscal year ending December 31, 2022.

Key Points: 
  • MUNICH, April 27, 2023 – Mynaric (NASDAQ: MYNA) (FRA: M0YN), a leading provider of industrialized, cost-effective and scalable laser communications products, today announces preliminary unaudited results for the fiscal year ending December 31, 2022.
  • “Mynaric finished 2022 with a solid terminal order backlog and is well positioned to capitalize on the significant opportunity ahead of us as the adoption of laser communications accelerates in both the space and airborne domains,” said Bulent Altan and Mustafa Veziroglu, Co-CEOs of Mynaric.
  • Mynaric is providing the following key performance indicators outlook for 2023:
    Mynaric has scheduled a webcast to discuss its preliminary unaudited full-year 2022 financial results to be held today, Thursday, April 27, 2023, at 12:00 p.m. Eastern Daylight Time (6:00 p.m. Central European Summer Time).
  • The conference call and webcast will include a presentation of these results along with a Q&A session with Mynaric executives including Co-CEOs, Bulent Altan and Mustafa Veziroglu, and CFO, Stefan Berndt-von Bülow.

Ubie signs a broad collaboration agreement with Takeda Pharmaceuticals to promote digital transformation

Retrieved on: 
Thursday, April 27, 2023
Learning, Face, International Working Group on Neurotransmitter Related Disorders, Takeda, HAWK, E pluribus unum, Edema, Hereditary angioedema, Angioedema, Asphyxia, Asthma, HAE, Genetic disorder, Patient, Physician, Risk, Abdomen, Diagnosis, Rare, Health, Audi Q5, Disease, Pharmaceutical industry, Nursing

NEW YORK, April 27, 2023 /PRNewswire/ -- Ubie Inc. has signed a comprehensive collaboration agreement with Takeda Pharmaceutical Co., Ltd. to promote digital transformation, which aims to guide people to appropriate medical care for rare diseases and gastrointestinal diseases.

Key Points: 
  • NEW YORK, April 27, 2023 /PRNewswire/ -- Ubie Inc. has signed a comprehensive collaboration agreement with Takeda Pharmaceutical Co., Ltd. to promote digital transformation, which aims to guide people to appropriate medical care for rare diseases and gastrointestinal diseases.
  • Since April 2021, Ubie and Takeda Pharmaceutical Co., Ltd. have been promoting digital transformation for the early detection of diseases and guidance for appropriate medical examinations using Ubie Symptom Checker, a service for general public with disease concerns, and Ubie Patient Intake Form, a service for medical institutions.
  • (*2,3,4) If it lodges in the throat, it can block the airway, causing difficulty breathing and the elevating risk of suffocation.
  • Ubie, in collaboration with Takeda, will contribute to the health of as many patients as possible by supporting patient journeys through the active use of technology.

EQS-News: Mynaric delivers CONDOR Mk2 terminals to Telesat Government Solutions for DARPA’s Blackjack program

Retrieved on: 
Monday, February 13, 2023
FRA, Starcom: The U.S. Space Force, MK2, Croupier, TSAT, HAWK, DARPA, GS, TSX, Telesat, CONDOR, Blackjack, LOS, Communications satellite, Mynaric

LOS ANGELES and MUNICH, February 8, 2023 – Mynaric (NASDAQ: MYNA) (FRA: M0YN), a leading provider of industrialized, cost-effective, and scalable laser communications products, today announced the delivery of multiple CONDOR Mk2 optical communications terminals to Telesat Government Solutions (GS), a wholly-owned U.S.-based subsidiary of leading satellite operator Telesat (NASDAQ and TSX: TSAT).

Key Points: 
  • LOS ANGELES and MUNICH, February 8, 2023 – Mynaric (NASDAQ: MYNA) (FRA: M0YN), a leading provider of industrialized, cost-effective, and scalable laser communications products, today announced the delivery of multiple CONDOR Mk2 optical communications terminals to Telesat Government Solutions (GS), a wholly-owned U.S.-based subsidiary of leading satellite operator Telesat (NASDAQ and TSX: TSAT).
  • Mynaric’s first delivery of flight-ready CONDOR optical communications terminals for space applications marks an important milestone towards the product family’s space flight heritage.
  • In Q4 2020, Mynaric was selected by Telesat GS to supply optical communications terminals to the Blackjack satellite program which were now delivered.
  • The delivery of flight-ready CONDOR Mk2 units to Telesat GS follows shortly after Mynaric’s delivery of HAWK units to an energy customer in Q4 2022.

EQS-News: Mynaric delivers HAWK terminals to new commercial U.S.-based energy customer

Retrieved on: 
Monday, November 28, 2022
LOS, CCO, Communication, App Store (iOS/iPadOS), Learning, Pacific typhoon season, Atmosphere, HAWK, FRA, 3D printing, Communications satellite, Mynaric

LOS ANGELES and MUNICH, November 28, 2022 Mynaric (NASDAQ: MYNA) (FRA: M0YN), a leading provider of industrialized, cost-effective, and scalable laser communications products, today announced the delivery of a set of multiple HAWK optical communications terminals for an initial test campaign to a commercial U.S.-based energy customer.

Key Points: 
  • LOS ANGELES and MUNICH, November 28, 2022 Mynaric (NASDAQ: MYNA) (FRA: M0YN), a leading provider of industrialized, cost-effective, and scalable laser communications products, today announced the delivery of a set of multiple HAWK optical communications terminals for an initial test campaign to a commercial U.S.-based energy customer.
  • The terminals are intended to be utilized in disaster recovery missions where satellite or terrestrial communications infrastructure has been compromised.
  • Today marks an exciting day as our team ships HAWK products to a commercial energy customer in the United States, said Tina Ghataore, CCO of Mynaric.
  • Mynaric (NASDAQ: MYNA) (FRA: M0YN) is leading the industrial revolution of laser communications by producing optical communications terminals for air, space and mobile applications.

Takeda’s TAKHZYRO® (lanadelumab-flyo) Prefilled Syringe Now Available for People With Hereditary Angioedema (HAE) Ages 12 Years and Older in the United States

Retrieved on: 
Monday, April 18, 2022
Medical Supplies, Health, FDA, General Health, Clinical Trials, Pharmaceutical, Biotechnology, Projection, Lists of diseases, Pain, U.S. Securities and Exchange Commission, Veni, vidi, vici, Bruise, Woman, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, HAE, Annual report, Diagnosis, Caregiver, Hereditary angioedema, Science, Abdomen, Food, R, HAWK, Red, Vaccine, Patient, HELP, International Work Group for Indigenous Affairs, Information, Edema, Hematology, Advertising, Headache, Genetics, Takeda Pharmaceutical Company, Acquisition, Investment, Safety, Angioedema, FDA, Disease, Respiratory tract, Risk, Face, Quality of life, Swelling, Birth control, Pharmaceutical industry, Gastroenterology, Neuroscience, Takeda

TAKHZYRO is a prescription medicine used to prevent attacks of hereditary angioedema (HAE) in people 12 years of age and older.

Key Points: 
  • TAKHZYRO is a prescription medicine used to prevent attacks of hereditary angioedema (HAE) in people 12 years of age and older.
  • It is not known if TAKHZYRO is safe and effective in children under 12 years of age.
  • The patient or caregiver should be trained by a healthcare professional.1 TAKHZYRO is currently approved and available in more than 30 countries around the world.
  • Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group.

Takeda’s TAKHZYRO® (lanadelumab) Open Label Phase 3 Study Met Its Objectives in Children Ages 2 to <12 Years of Age With Hereditary Angioedema (HAE)

Retrieved on: 
Tuesday, April 12, 2022
Health, Clinical Trials, Research, Pharmaceutical, Science, Biotechnology, Projection, U.S. Securities and Exchange Commission, Tongue, HAE, Annual report, Diagnosis, Caregiver, Hereditary angioedema, Genetic disorder, Abdomen, Science, R, HAWK, Itch, Edema, Vaccine, Patient, International Work Group for Indigenous Affairs, Information, Failure, Hematology, Advertising, Genetics, Takeda Pharmaceutical Company, Investment, Safety, Product, Angioedema, Acquisition, Disease, Face, Quality of life, Swelling, Medical device, Pharmaceutical industry, Gastroenterology, Neuroscience, Takeda

For full U.S. Prescribing Information, including the approved indication and important safety information, please visit https://www.shirecontent.com/PI/PDFs/TAKHZYRO_USA_ENG.pdf .

Key Points: 
  • For full U.S. Prescribing Information, including the approved indication and important safety information, please visit https://www.shirecontent.com/PI/PDFs/TAKHZYRO_USA_ENG.pdf .
  • Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetics and Hematology, Neuroscience, and Gastroenterology (GI).
  • 4Cicardi M, Bork K, Caballero T, et al; on behalf of HAWK (Hereditary Angioedema International Working Group).
  • Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group.

DGAP-News: Mynaric exhibiting, presenting and holding live demo at SATELLITE 2022

Retrieved on: 
Monday, March 21, 2022
Future Air Navigation System, NASDAQ, Aloha from Hawaii via Satellite, News, FRA, DGAP, Research, Inter-satellite service, Atmosphere, Communication, App Store (iOS/iPadOS), RF, Satellite, Industry, Technology, HAWK, Solution, Awareness, Happening, LOS, Leadership, Space, Security (finance), Communications satellite, Television, Mynaric

LOS ANGELES, March 21, 2022 - Mynaric will exhibit at SATELLITE 2022 from March 21-24, showcasing a public product demonstration of our HAWK Optical Communication Terminal for the first time.

Key Points: 
  • LOS ANGELES, March 21, 2022 - Mynaric will exhibit at SATELLITE 2022 from March 21-24, showcasing a public product demonstration of our HAWK Optical Communication Terminal for the first time.
  • "Every year, we look forward to SATELLITE as it's a pivotal event for the industry as a whole, elevating the latest innovations in space technology and research," said Mynaric CEO Bulent Altan.
  • Leveraging its HAWK terminals suited for air operations, Mynaric will publicly display its technology in action for the first time at SATELLITE.
  • In its live, bidirectional 10Gbps optical link demonstration, Mynaric will showcase the stable and reliable connection between two linked HAWK terminals.